Jubilant Pharmova Ltd
NSE:JUBLPHARMA
Wall Street
Price Targets
JUBLPHARMA Price Targets Summary
Jubilant Pharmova Ltd
According to Wall Street analysts, the average 1-year price target for
JUBLPHARMA
is 1 303.05 INR
with a low forecast of 1 186.75 INR and a high forecast of 1 391.25 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is JUBLPHARMA's stock price target?
Price Target
1 303.05
INR
According to Wall Street analysts, the average 1-year price target for
JUBLPHARMA
is 1 303.05 INR
with a low forecast of 1 186.75 INR and a high forecast of 1 391.25 INR.
What is Jubilant Pharmova Ltd's Revenue forecast?
Projected CAGR
14%
For the last 13 years the
compound annual growth rate for
Jubilant Pharmova Ltd's revenue is
4%.
The projected
CAGR
for the next 3 years is
14%.
What is Jubilant Pharmova Ltd's Operating Income forecast?
Projected CAGR
17%
For the last 13 years the
compound annual growth rate for
Jubilant Pharmova Ltd's operating income is
1%.
The projected
CAGR
for the next 3 years is
17%.
What is Jubilant Pharmova Ltd's Net Income forecast?
Projected CAGR
-2%
For the last 13 years the
compound annual growth rate for
Jubilant Pharmova Ltd's net income is
37%.
The projected
CAGR
for the next 3 years is
-2%.
